Refine
Has Fulltext
- yes (48)
Is part of the Bibliography
- yes (48)
Year of publication
- 2020 (48) (remove)
Document Type
- Doctoral Thesis (27)
- Journal article (21)
Keywords
- adrenocortical carcinoma (5)
- Herzinsuffizienz (4)
- Fabry disease (3)
- Hyperaldosteronismus (3)
- Aldosteron (2)
- CXCR4 (2)
- Morbus Fabry (2)
- Nebenniere (2)
- Nebennierenrindeninsuffizienz (2)
- Simulation (2)
- biomarker (2)
- immune response (2)
- mouse (2)
- 1-Methylnicotinamid (1)
- ARDS (acute respiratory distress syndrome) (1)
- ASE formula (1)
- Adhärenz (1)
- Adipokine (1)
- Adiponektin (1)
- Adipositas (1)
- Agalsidase beta (1)
- Aging (1)
- Akutes Nierenversagen (1)
- Akutes ischämisches Nierenversagen (1)
- Akzeptanz (1)
- Aldosteronism (1)
- Aldosteronismus (1)
- Aldosteronsynthase-Inhibitor (1)
- Anämie (1)
- Aortenklappenstenose (1)
- Arrhythmie (1)
- Autoantikörper (1)
- Autoimmun polyglanduläres Syndrom Typ 2 (1)
- Basischarakteristika (1)
- Beta-1-Rezeptor (1)
- Brownian ratchet (1)
- COVID-19 (1)
- CXCR7 (1)
- CYP11B1 (1)
- CYP11B2 (1)
- CYP2B6 (1)
- CYP2W1 (1)
- Ca cycling (1)
- Cardiomyopathy (1)
- Chemokine (1)
- Chemokinrezeptor (1)
- Coronavirus Disease 2019 (1)
- DF-Testung (1)
- DFT (1)
- Depression (1)
- Diabetes mellitus Typ 1 (1)
- Dumping Syndrom (1)
- Dumping-Syndrome (1)
- ETiCS (1)
- Eisenmangel (1)
- End-of-Life Care (1)
- End-of-Life Decision (1)
- Endokrinopathie (1)
- Entscheidungsunterstützungssystem (1)
- Enzyme replacement therapy (1)
- Erwartungshaltung (1)
- Evaluation (1)
- Fabry Stabilization Index (1)
- Fabry genotype (1)
- Fabry phenotype (1)
- Fabry-Kardiomyopathie (1)
- Fabry-Krankheit (1)
- Female patients (1)
- Fettzelle (1)
- Gemcitabin (1)
- Germany (1)
- Glukosestoffwechsel (1)
- HCM (1)
- HFmrEF (1)
- Heart (1)
- Herzfrequenzvariabilität (1)
- Herzinfarkt (1)
- Herzkatheter (1)
- Hypoglycemia (1)
- Immunsystem (1)
- Implantierbare Kardioverter Defibrillatoren (1)
- Intensive Care (1)
- Intensivmedizin (1)
- Jugendliche (1)
- Kardiomyopathie (1)
- Kidney function (1)
- Kinder (1)
- Kinetik der Sauerstoffaufnahme (1)
- Koronarintervention (1)
- Lebensqualität (1)
- Leptine (1)
- Lipolyse (1)
- Loop recorder (1)
- Lyso-GB3 (1)
- Lysosomale Speicherkrankheit (1)
- MEN1 (1)
- Magenbypass (1)
- Mausmodell (1)
- Metoprolol Tartrat (1)
- Mittelgradige Aortenklappenstenose (1)
- Morbus Cushing (1)
- Mutation (1)
- Myokardinfarkt (1)
- Myokarditis (1)
- Nebenniereninsuffizienz (1)
- Nebennierenrindenkarzinom (1)
- Nebennierenvenenkatheter (1)
- Nebivolol (1)
- Neoplasma (1)
- Neprilysin inhibition (1)
- Nicotinamid-N-Methyltransferase (1)
- Niereninsuffizienz (1)
- Normierung (1)
- ORO (1)
- Oil-Red-O (1)
- PET-Tracer (1)
- PHQ-2 (1)
- PHQ-9 (1)
- Pathogenese (1)
- Patientenschulung (1)
- Positronen-Emissions-Tomografie (1)
- Postoperative Hypoglykämie (1)
- Prognose (1)
- Prostaglandin E2 (1)
- Prostaglandin E2-Ausscheidung (1)
- Qualitative Content Analysis (1)
- Qualitative Inhaltsanalyse (1)
- RRM1 (1)
- RYGB (1)
- Roux-en-Y gastric bypass (1)
- SCD-Risko nach PTSMA (1)
- SG (1)
- SNP (1)
- SOAT1 (1)
- SR Ca leak (1)
- ST-elevation myocardial infarction (1)
- Sarcoidosis (1)
- Sarkoidose (1)
- Sauerstoffaufnahme (1)
- Schlauchmagen (1)
- Schockeffektivität (1)
- Schocktestung (1)
- Schulungsprogramm (1)
- Sekundäre Hypertonie (1)
- Sekundärneoplasie (1)
- Sekundärtumor (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- Simulationstraining (1)
- Slow Component der Sauerstoffaufnahme (1)
- Strahlenbelastung (1)
- Sudden death (1)
- Sudden death Risk after PTSMA (1)
- Teichholz formula (1)
- Therapiebegrenzung (1)
- Therapiezieländerung (1)
- Training (1)
- USP8 (1)
- Verdachtsüberprüfung (1)
- Vorhofflimmern (1)
- Zetrales Cushing Syndrom (1)
- acute respiratory distress syndrome (1)
- adherence (1)
- aldosterone (1)
- aldostoreone synthase inhibitor (1)
- allocation (1)
- animal models of human disease (1)
- anti-drug antibodies (1)
- apolipoprotein-E (1)
- arrhythmia (1)
- arrhythmogenic cardiomyopathy (1)
- arterielle Hypertonie (1)
- association (1)
- atheriosclerosis (1)
- autoantibodies (1)
- autoimmune polyglandular syndrome type 2 (1)
- blood coagulation factor XIII (1)
- blood flow (1)
- blood–brain barrier (1)
- bone (1)
- brain pathology (1)
- cancer-testis antigens (1)
- candidate genes (1)
- capecitabine (1)
- cardiac magnetic resonance imaging (1)
- cardiogenetics (1)
- cardiomyopathy (1)
- channel transport (1)
- chemokine receptor (1)
- child (1)
- circulating microRNA (1)
- co-morbid depression (1)
- cortisol (1)
- cytokines (1)
- desmosomes (1)
- drug transporter (1)
- early prognosis (1)
- echocardiography (1)
- entresto (1)
- entropy production (1)
- enzyme replacement therapy (1)
- expectations (1)
- flow patterns (1)
- fourth (1)
- free energy (1)
- genetics (1)
- graft (1)
- growth differentiation factor 15 (1)
- hENT1 (1)
- healing and remodelling processes (1)
- heart failure (1)
- hemodialysis (1)
- hypertension (1)
- immunity (1)
- immunotherapy (1)
- inflammation (1)
- intensive care medicine (1)
- interparticle interaction (1)
- kidney (1)
- kidney ischemia/reperfusion injury (1)
- kinetics of oxygen uptake (1)
- komorbide Depression (1)
- left ventricular hypertrophy (1)
- left ventricular mass index (1)
- lesions (1)
- loss (1)
- lymphocytes (1)
- lyso‐Gb3 (1)
- miR-483-5p (1)
- miRNA (1)
- mice (1)
- mineral bone density (1)
- mitotane (1)
- myocardial infarction (1)
- neoplasm (1)
- neuroendocrine tumor (1)
- non-equilibrium thermodynamics (1)
- oral chemotherapy (1)
- orale Chemotherapie (1)
- osteoporosis (1)
- overweight simulation (1)
- pandemia (1)
- phase-contrast MRI (1)
- prediction model (1)
- predictive biomarker (1)
- predictive marker (1)
- primary aldosteronism (1)
- primärer Hyperaldosteronismus (1)
- prognosis (1)
- prognostic biomarker (1)
- prognostic factors (1)
- prognostischer Marker (1)
- prädiktiver Marker (1)
- quantification (1)
- recurrence (1)
- repeated (1)
- re‐transplantation (1)
- serotonin (1)
- sleeve gastrectomy (1)
- slow component of oxygen uptake (1)
- state space (1)
- statistical mechanics (1)
- sudden death (1)
- survival (1)
- t-lymphocytes (1)
- target therapies (1)
- targeted gene panel (1)
- therapy (1)
- thermodynamics (1)
- third (1)
- tight junctions (1)
- tumor microenvironment (1)
- tumor-infiltrating (1)
- verification of suspected diagnoses (1)
- vitamin D (1)
- whole exome sequencing (1)
- zebrafish (1)
- Übergewicht (1)
- Übergewichts-Simulation (1)
- α‐GalA 3D‐structure (1)
Institute
- Medizinische Klinik und Poliklinik I (48) (remove)
Sonstige beteiligte Institutionen
Fabry Disease (FD) is a rare, X-linked, lysosomal storage disease that mainly causes renal, cardiac and cerebral complications. Enzyme replacement therapy (ERT) with recombinant alpha-galactosidase A is available, but approximately 50% of male patients with classical FD develop inhibiting anti-drug antibodies (iADAs) that lead to reduced biochemical responses and an accelerated loss of renal function. Once immunization has occurred, iADAs tend to persist and tolerization is hard to achieve. Here we developed a pre-treatment prediction model for iADA development in FD using existing data from 120 classical male FD patients from three European centers, treated with ERT. We found that nonsense and frameshift mutations in the α-galactosidase A gene (p = 0.05), higher plasma lysoGb3 at baseline (p < 0.001) and agalsidase beta as first treatment (p = 0.006) were significantly associated with iADA development. Prediction performance of a Random Forest model, using multiple variables (AUC-ROC: 0.77) was compared to a logistic regression (LR) model using the three significantly associated variables (AUC-ROC: 0.77). The LR model can be used to determine iADA risk in individual FD patients prior to treatment initiation. This helps to determine in which patients adjusted treatment and/or immunomodulatory regimes may be considered to minimize iADA development risk.